Alpha-1-Acid Glycoprotein

Alpha-1-acid glycoprotein is a key acute-phase protein produced primarily by the liver. It plays an essential role in immune modulation, inflammation, and drug-binding dynamics. 

As a biomarker, alpha-1-acid glycoprotein provides valuable diagnostic insights, particularly in conditions involving inflammation, infection, and cancer. Its levels can also impact the pharmacokinetics of medications bound to plasma proteins. 

This article offers a concise overview of AAG, including its clinical significance, test interpretation, and its role in monitoring disease progression and treatment responses. 

What is Alpha-1-Acid Glycoprotein (AGP)?

Alpha-1-acid glycoprotein (AGP), also known as orosomucoid, is a major plasma protein primarily produced by the liver. As a positive acute-phase protein, AGP levels rise in response to inflammation, infection, tissue injury, and certain cancers. 

It plays a critical role in immune regulation, inflammation, and drug-binding, helping to transport various compounds, including medications. AGP also contributes to maintaining capillary barrier function and regulating metabolism, with key immunomodulatory effects, including the regulation of neutrophil activity. 

Its elevated levels are particularly significant during conditions like sepsis and shock, where it helps manage inflammation and support vital organ function.

 AGP is encoded by the ORM1 and ORM2 genes, with variations in these genes potentially influencing AGP levels in individuals. 

Clinical Significance of Alpha-1-Acid Glycoprotein (AGP)

AGP has been used as a biomarker in the following settings:

Sepsis and Mortality Prediction

Low AGP levels when patients first arrive at the emergency department are linked to a higher risk of dying within 96 hours, especially in those with septic shock.

AGP levels of 120 mg/dL or lower are strongly connected to an increased risk of death in septic patients.

Organ Dysfunction and Shock

AGP levels are related to signs of organ problems, like high lactate levels and the Sequential Organ Failure Assessment (SOFA) score.

Low AGP levels suggest severe organ issues, showing how it helps control inflammation and support blood vessel health during shock.

Prognostic Value in Sepsis

While AGP is not better than other tests like APACHE II or SOFA for predicting outcomes, it is very specific. It works well alongside these tests to understand the severity of sepsis.

AGP is easy and cheap to measure, making it a helpful tool in critical care.

Chronic Inflammation and Metabolic Conditions

High AGP levels are linked to a greater risk of problems like diabetes, heart disease, and metabolic syndrome.

It helps track how these long-term conditions progress and how well treatments work.

Cancer Prognosis

Increased alpha-1-acid glycoprotein (AGP) levels have been found in breast cancer tissues, with higher expression observed at later stages of the disease. This suggests that AGP could be a potential biomarker for monitoring breast cancer progression and possibly guiding treatment strategies.

Nutritional Assessment

AGP is used to adjust other nutritional tests, like those for iron and vitamin A, when inflammation is present, helping doctors get more accurate results.

This is especially useful in large population surveys or in clinical settings where inflammation might affect other test results.

In short, AGP is an important marker for tracking inflammation, checking how diseases are progressing, and making treatment decisions in cases like sepsis, chronic diseases, cancer, and nutritional assessments.

Who Should Get Alpha-1-Acid Glycoprotein Tested?

The following individuals may benefit from Alpha-1-acid glycoprotein testing under the guidance of a licensed healthcare professional:

Individuals with Inflammatory Conditions

AGP testing may be useful in diagnosing and monitoring inflammatory diseases like rheumatoid arthritis, lupus, and Crohn's disease. Elevated AGP levels can provide insight into disease severity and help assess treatment responses.

Cancer Patients

AGP may be a potential prognostic marker for some cancers in oncology. Its levels are associated with tumor progression and immune system modulation, providing clinicians with important information about disease activity.

Patients Undergoing Drug Therapy

For patients on drugs like propranolol or warfarin, which are heavily bound to plasma proteins, AGP testing can help predict drug distribution and toxicity. AGP levels may also affect drug levels, how drugs are metabolized, and their effectiveness.

Testing Procedure

The AGP blood test is a simple diagnostic procedure that measures AGP levels in serum.  Testing involves drawing a blood sample from a vein. Fasting may be required; speak with the ordering provider to confirm whether fasting is necessary.

Test Interpretation

Test results should be interpreted by a medical professional.

Normal Levels

While reference ranges may vary depending on the lab company used, one reference reports the following normal ranges:

Reference Values 

Adults:  39 – 115 mg/dL

What Do High Levels of Alpha-1-Acid Glycoprotein Mean?

High AGP levels are commonly seen in response to acute or chronic inflammation, infection, or tissue injury. It is an important marker in conditions like sepsis and systemic inflammation. Additionally, elevated AGP levels can be associated with cancer progression or chronic kidney disease.

What Do Low Levels of Alpha-1-Acid Glycoprotein Mean?

Low AGP levels can indicate liver dysfunction, malnutrition, or severe trauma. It is often seen in advanced liver disease, protein-losing enteropathy, and conditions that result in protein loss. Low APG levels may also be related to impaired immune function.

Potential Health Implications

AGP levels can also affect drug pharmacokinetics, leading to increased or decreased free drug concentrations in the bloodstream. In patients with low AGP levels, this can result in higher drug toxicity, particularly in patients on medications that rely heavily on plasma protein binding.

Conclusion

Alpha-1-acid glycoprotein is an important biomarker in clinical settings, providing valuable insights into inflammation, immune responses, and drug pharmacokinetics. 

By understanding its role in diseases like rheumatoid arthritis, lupus, cancer, and liver dysfunction, clinicians can better monitor patient health and optimize treatment plans. 

AGP levels can guide therapeutic decisions, especially for patients with high plasma protein binding medications, ensuring effective and safe treatment.

Order Alpha-1-Acid Glycoprotein Testing

Click here to compare testing options and order testing for alpha-1-acid glycoprotein.